Labcorp 

€224.00
0
-€22.00-8.94% Thursday 14:13

Statistics

Day High
224
Day Low
224
52W High
246
52W Low
224
Volume
2
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
1.1%
Dividend
2.47

Upcoming

Dividends

1.1%Dividend Yield
Jun 26
€0.62
Mar 26
€0.61
Dec 25
€0.62
Sep 25
€0.62
Jun 25
€0.63
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
-3.91%

Earnings

30JulExpected
Q1 2026
Next
3.5
3.73
3.96
4.19
Expected EPS
4.187591625
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow N6B.XETRA. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcohol and other substance abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations. In addition, the company offers digital pathology solutions, a pathology platforms that support the digitization, centralized review, and sharing of pathology slides; provider and payer digital platforms, an online applications for providers, MCOs, and ACOs; online and mobile applications that enable patients to check offerings, schedule PSC visits, check-in upon PSC arrival, complete documentation, access tests and test results, and manage their accounts; and Generative AI-enabled Test Selection, a generative AI-enabled tool. It serves clients, third party, medicare/medicaid, patients, pharmaceutical, biotechnology, medical device, diagnostic companies, and CROs. The company has a strategic collaboration with the Children's Hospital of Philadelphia to accelerate the discovery, development, and availability of pediatric diagnostics. It also has a collaboration with Alliance for Clinical Trials in Oncology to advance national clinical trial for patients diagnosed with colorectal cancer. The company was founded in 1995 and is headquartered in Burlington, North
Show more...
CEO
ISIN
US5049221055
WKN
000A40C39

Listings

0 Comments

Share your thoughts

FAQ

What is Labcorp stock price today?
The current price of N6B.XETRA is €224.00 EUR — it has decreased by -8.94% in the past 24 hours. Watch Labcorp stock price performance more closely on the chart.
What is Labcorp stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Labcorp stocks are traded under the ticker N6B.XETRA.
When is the next Labcorp earnings date?
Labcorp is going to release the next earnings report on July 30, 2026.
What were Labcorp earnings last quarter?
N6B.XETRA earnings for the last quarter are 3.62 EUR per share, whereas the estimation was 3.5 EUR resulting in a +3.42% surprise. The estimated earnings for the next quarter are N/A EUR per share.
Does Labcorp pay dividends?
Yes, N6B.XETRA dividends are paid quarterly. The last dividend per share was 0.62 EUR. As of today, Dividend Yield (FWD)% is 1.1%.
In which sector is Labcorp located?
Labcorp operates in the Other sector.
When did Labcorp complete a stock split?
The last stock split for Labcorp was on July 03, 2023 with a ratio of 1164:1000.